OPGEN INC OPGN Income Statement

Opgen inc (OPGN)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue
Total revenue
616	820	648	1,009	1,020	758	552	788	846	-	745	703	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	734	818	730	1,028	947	1,268	929	319	184	394	268	272	300
Laboratory services
-	-	-	-	-	-	-	-	-	-	-	-	16	46	23	29	129	33	23	28	35	99	88	121	169
Collaboration revenue
-	-	-	-	-	-	-	-	-	-	-	-	21	141	6	125	0	27	27	27	252	627	477	677	627
Total revenue
-	-	-	-	-	-	-	-	-	-	-	-	771	1,006	759	1,182	1,076	1,329	980	375	472	1,122	834	1,072	1,097
Operating expenses
Cost of products sold (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	101	-	-
Cost of services (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	129	-	-
Total costs of sales (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	230	-	-
Gross profit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	604	-	-
Cost of products sold
-	-	-	-	-	-	-	-	-	-	-	-	424	575	400	337	345	391	624	48	115	-	-	65	136
Cost of services
-	-	-	-	-	-	-	-	-	-	-	-	100	102	51	161	315	169	48	54	95	-	-	140	97
Research and development
1,217	1,051	1,139	1,153	1,776	1,856	1,286	1,304	1,230	1,485	1,513	1,762	2,122	2,147	2,178	2,333	1,953	2,105	1,788	999	1,108	1,138	1,029	1,247	952
General and administrative
1,701	1,351	1,560	1,592	1,747	1,704	1,743	1,831	1,790	1,372	1,600	1,750	1,969	1,647	1,639	1,777	1,538	2,140	1,614	1,420	659	679	555	523	554
Sales and marketing
282	321	376	393	372	414	361	426	329	422	330	909	1,105	1,246	1,294	1,588	1,399	1,342	1,032	905	1,024	504	459	546	547
Transaction costs
245	-	538	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of right-of-use asset
-	0	0	0	520	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangibles assets
750	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	141	-	-
Transaction expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	525	-	-	-	0	-	-
Total operating expenses
4,611	3,323	4,073	3,590	4,782	4,437	3,782	4,044	3,862	3,919	3,941	4,893	5,722	5,719	5,565	6,197	5,552	-	5,634	-	-	-	-	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,428	3,002	2,694	2,185	2,522	2,289
Operating loss
-3,994	-2,502	-3,425	-2,580	-3,761	-3,678	-3,230	-3,255	-3,015	-2,928	-3,196	-4,189	-4,950	-4,713	-4,805	-5,014	-4,475	-4,821	-4,653	-3,053	-2,530	-1,341	-1,580	-1,449	-1,192
Other income (expense)
Other income (expense)
-	-	1	15	-	-	-0	0	5	-	-87	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Interest and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Interest and other income (expense)
87	-	-	-	-24	-	-	-	-	-	-	0	0	-	-	-3	0	-	2	7	-	-	-	-	-
Interest expense
38	44	49	37	56	50	28	54	57	59	90	53	29	33	41	26	41	54	17	1,632	96	63	32	6	8
Foreign currency transaction losses
-3	11	-8	9	-10	-3	3	-21	12	3	8	8	2	-10	-1	-7	11	0	0	0	0	-	-	-	-
Change in fair value of derivative financial instruments
-	0	0	0	0	0	-0	-0	8	19	97	26	0	-	0	-	-	0	0	-679	31	-	-	-	-
Changes in fair value of warrant liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-4	0	-
Total other income (expense)
45	-14	-57	-12	-91	-54	-25	-76	-32	-36	-72	-18	-27	-46	-42	-38	-30	-37	-14	-2,305	-64	-63	-27	-6	-8
Loss before income taxes
-3,949	-2,517	-3,482	-2,593	-3,853	-3,732	-3,255	-3,332	-3,048	-2,964	-3,268	-4,208	-4,977	-4,760	-4,847	-5,052	-4,506	-	-4,668	-	-	-	-	-	-
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,608	-	-
Provision for income taxes
-	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	-	1	-	-	-	0	-	-
Net loss
-3,949	-2,517	-3,482	-2,593	-3,853	-3,732	-3,255	-3,332	-3,048	-2,964	-3,268	-4,208	-4,977	-4,760	-4,847	-5,052	-4,506	-4,727	-4,670	-5,358	-2,595	-1,405	-1,608	-1,456	-1,200
Preferred stock dividends and beneficial conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	332	0	-	0	72	-	-	-	-	-
Preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	171	-	175	172	110
Net loss available to common stockholders
-3,949	-	-3,482	-2,593	-3,853	-	-3,255	-3,332	-3,048	-	-3,268	-4,208	-4,977	-4,760	-4,847	-5,385	-4,506	-4,726	-4,670	-5,431	-2,766	-1,573	-1,784	-1,629	-1,311
Net loss per common share - basic and diluted
-0.53	4.65	-3.95	-0.15	-8.25	-32.50	-10.67	-0.57	-0.75	0.44	-1.74	-3.73	-4.77	-21.11	-5.75	-0.37	-0.36	-48.17	-0.38	-0.84	-5.61	-3.22	-4.92	-4.49	-3.62
Weighted average shares outstanding - basic and diluted
7,393	-12,527	882	17,645	467	-8,986	305	5,826	4,055	2,240	1,883	1,128	1,043	-25,101	837	14,522	12,568	-17,926	12,261	6,449	493	462	362	362	362
Net loss
-3,949	-2,517	-3,482	-2,593	-3,853	-3,732	-3,255	-3,332	-3,048	-2,964	-3,268	-4,208	-4,977	-4,760	-4,847	-5,052	-4,506	-4,727	-4,670	-5,358	-2,595	-1,405	-1,608	-1,456	-1,200
Other comprehensive income - foreign currency translations
39	-9	7	-4	2	5	1	18	-12	-18	-6	-3	-3	6	0	1	-1	-1	-0	0	0	-	0	-	-
Comprehensive loss
-3,909	-2,527	-3,475	-2,597	-3,850	-3,726	-3,253	-3,314	-3,060	-2,982	-3,274	-4,211	-4,981	-4,753	-4,846	-5,051	-4,507	-4,728	-4,670	-5,358	-2,595	-	-1,608	-	-
Product sales [Member]
Total revenue
366	570	573	504	520	589	539	632	633	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of products and services
276	229	262	198	220	283	292	303	342	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Laboratory Service Revenue [Member]
Total revenue
-	-	0	5	-	12	12	1	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaborations Revenue [Member]
Total revenue
250	250	75	500	500	156	0	155	204	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service [Member]
Cost of products and services
137	127	196	251	144	179	98	179	168	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-